Healthpeak Properties (NYSE:DOC) PT Set at $21.00 by Robert W. Baird

Healthpeak Properties (NYSE:DOC) has been assigned a $21.00 target price by equities research analysts at Robert W. Baird in a research report issued on Wednesday, MarketBeat reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s target price indicates a potential upside of 23.87% from the company’s current price.

DOC has been the topic of several other research reports. Wedbush dropped their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. Argus reissued a “buy” rating and set a $25.00 target price on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Evercore ISI lowered their price target on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Scotiabank downgraded Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and reduced their price objective for the stock from $21.00 to $19.00 in a research report on Tuesday. Finally, Wall Street Zen lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, July 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $23.00.

Healthpeak Properties Stock Down 1.6%

Shares of DOC stock opened at $16.95 on Wednesday. Healthpeak Properties has a 12 month low of $16.64 and a 12 month high of $23.26. The firm has a market cap of $11.78 billion, a PE ratio of 70.64, a price-to-earnings-growth ratio of 2.20 and a beta of 1.03. The stock has a 50 day moving average of $17.69 and a 200-day moving average of $18.77. The company has a quick ratio of 1.35, a current ratio of 1.28 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. Healthpeak Properties’s quarterly revenue was down .2% on a year-over-year basis. During the same quarter last year, the company posted $0.45 earnings per share. On average, equities analysts predict that Healthpeak Properties will post 1.86 EPS for the current year.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 2,930 shares of Healthpeak Properties stock in a transaction dated Thursday, July 31st. The shares were bought at an average price of $17.06 per share, for a total transaction of $49,985.80. Following the purchase, the chief executive officer owned 210,416 shares of the company’s stock, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Tommy G. Thompson bought 5,777 shares of the stock in a transaction dated Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director owned 144,290 shares in the company, valued at $2,491,888.30. The trade was a 4.17% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 20,030 shares of company stock worth $346,519. 0.23% of the stock is owned by insiders.

Hedge Funds Weigh In On Healthpeak Properties

Institutional investors have recently added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC increased its holdings in shares of Healthpeak Properties by 2.4% during the second quarter. Fifth Third Wealth Advisors LLC now owns 22,811 shares of the real estate investment trust’s stock worth $399,000 after buying an additional 543 shares in the last quarter. Parallel Advisors LLC increased its holdings in Healthpeak Properties by 4.2% during the 1st quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust’s stock valued at $283,000 after purchasing an additional 561 shares in the last quarter. Applied Finance Capital Management LLC raised its position in Healthpeak Properties by 3.4% in the 1st quarter. Applied Finance Capital Management LLC now owns 17,648 shares of the real estate investment trust’s stock valued at $357,000 after purchasing an additional 577 shares during the last quarter. Townsquare Capital LLC raised its position in Healthpeak Properties by 5.9% in the 4th quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust’s stock valued at $212,000 after purchasing an additional 584 shares during the last quarter. Finally, Huntington National Bank boosted its stake in Healthpeak Properties by 3.0% in the fourth quarter. Huntington National Bank now owns 20,843 shares of the real estate investment trust’s stock worth $422,000 after purchasing an additional 613 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.